129 related articles for article (PubMed ID: 17568031)
1. Clinical practice. Follow-up of patients with early breast cancer.
Hayes DF
N Engl J Med; 2007 Jun; 356(24):2505-13. PubMed ID: 17568031
[No Abstract] [Full Text] [Related]
2. Primary care for survivors of breast cancer.
Burstein HJ; Winer EP
N Engl J Med; 2000 Oct; 343(15):1086-94. PubMed ID: 11027744
[No Abstract] [Full Text] [Related]
3. Primary care issues for the breast cancer survivor.
Bines J; Gradishar WJ
Compr Ther; 1997 Sep; 23(9):605-11. PubMed ID: 9285161
[TBL] [Abstract][Full Text] [Related]
4. After breast cancer. Patient follow-up in the primary care setting.
Edwards AS
Adv Nurse Pract; 2004 Dec; 12(12):37-42. PubMed ID: 15615220
[No Abstract] [Full Text] [Related]
5. Late effects of pediatric cancer treatment come into sharper focus, predictive tests are emerging.
McNeil C
J Natl Cancer Inst; 2006 Jul; 98(13):882-4. PubMed ID: 16818847
[No Abstract] [Full Text] [Related]
6. Follow-up of patients with early breast cancer.
Butsch WS; Munoz AJ; Heimburger DC
N Engl J Med; 2007 Sep; 357(10):1053; author reply 1053. PubMed ID: 17823995
[No Abstract] [Full Text] [Related]
7. Integrative tumor board: recurrent breast cancer or new primary? Case Presentation.
Schmaltz J
Integr Cancer Ther; 2003 Sep; 2(3):268-70. PubMed ID: 15035889
[No Abstract] [Full Text] [Related]
8. Follow-up care of patients with breast cancer.
Tolaney SM; Winer EP
Breast; 2007 Dec; 16 Suppl 2():S45-50. PubMed ID: 17697780
[TBL] [Abstract][Full Text] [Related]
9. Integrative tumor board: recurrent breast cancer or new primary? Radiation oncology.
Hirsch A
Integr Cancer Ther; 2003 Sep; 2(3):272-6. PubMed ID: 15035891
[No Abstract] [Full Text] [Related]
10. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
Garg AK; Strom EA; McNeese MD; Buzdar AU; Hortobagyi GN; Kuerer HM; Perkins GH; Singletary SE; Hunt KK; Sahin A; Schechter N; Valero V; Tucker SL; Buchholz TA
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):138-45. PubMed ID: 15093909
[TBL] [Abstract][Full Text] [Related]
11. Integrative tumor board: recurrent breast cancer or new primary? Naturopathic medicine.
Fulop JA
Integr Cancer Ther; 2003 Sep; 2(3):276-83. PubMed ID: 15035892
[No Abstract] [Full Text] [Related]
12. Randomized clinical trials in breast cancer: a tabular summary. Part 1: Primary breast cancer.
Conrad B; Kieser R
Arch Geschwulstforsch; 1986; 56(3):211-36. PubMed ID: 3524501
[TBL] [Abstract][Full Text] [Related]
13. Integrative tumor board: recurrent breast cancer or new primary? Mind-body-spirit medicine.
Mehl-Madrona L
Integr Cancer Ther; 2003 Sep; 2(3):283-9. PubMed ID: 15035893
[No Abstract] [Full Text] [Related]
14. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
[TBL] [Abstract][Full Text] [Related]
15. Local therapy and survival in breast cancer.
Punglia RS; Morrow M; Winer EP; Harris JR
N Engl J Med; 2007 Jun; 356(23):2399-405. PubMed ID: 17554121
[No Abstract] [Full Text] [Related]
16. [Errors in the treatment of breast cancer].
Demidov VP; Pak DD; Ostrovtsev LD
Khirurgiia (Mosk); 1990 Apr; (4):90-5. PubMed ID: 2374366
[No Abstract] [Full Text] [Related]
17. Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; de Wit R; Gietema JA; Horenblas S; Louwman MW; Ribot JG; Hoekstra HJ; Ouwens GM; Aleman BM; van Leeuwen FE
J Clin Oncol; 2007 Oct; 25(28):4370-8. PubMed ID: 17906202
[TBL] [Abstract][Full Text] [Related]
18. Integrative tumor board: recurrent breast cancer or new primary? UCSF Osher Center for Integrative Medicine and UCSF Carol Franc Buck Breast Care Center.
Jacobs BP; Burns B; Marya R; Chapman J; Stone B; Hwang S; Goldman M; Barrows K; Hamolsky D; Sampel K
Integr Cancer Ther; 2003 Sep; 2(3):289-300. PubMed ID: 15035894
[No Abstract] [Full Text] [Related]
19. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies.
; Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
J Clin Oncol; 2006 May; 24(15):2268-75. PubMed ID: 16618947
[TBL] [Abstract][Full Text] [Related]
20. Integrative tumor board: recurrent breast cancer or new primary? Medical oncology.
Boyd DB
Integr Cancer Ther; 2003 Sep; 2(3):270-2. PubMed ID: 15035890
[No Abstract] [Full Text] [Related]
[Next] [New Search]
